FIGURE 2.
Plasma concentration profiles of TQS‐168 following (a) single (Day 1) and (b) repeated (Day 7) oral administration of TQS‐168 SDD formulation (* denotes fed state).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.